Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations
- PMID: 3542005
- PMCID: PMC2001544
- DOI: 10.1038/bjc.1986.239
Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations
Abstract
Improvements to the original procedure of using a panel of monoclonal antibodies and magnetic microspheres for the depletion of tumour cells from bone marrow are described. These include a completely disposable system for the magnetic depletion of tumour cells coated with magnetic microspheres. Properties of a new series of microspheres are compared with the old M330 beads in their ability to deplete neuroblasts from both model systems and 50 bone marrows harvested from Stage IV neuroblastoma patients. Using human neuroblastoma cell lines labelled with the DNA intercalating, Hoechst dye 33342 a 5% tumour contamination can routinely be removed from 5 X 10(6) - 5 X 10(7) nucleated cells. Analysis of the 50 purged marrows revealed that 10 were visibly contaminated with tumour (by conventional cytology and immunological procedures). In all but one case, tumour cells were removed. In this instance the tumour:bead ratio fell to 1:4 indicating the importance of maintaining a sufficient number of beads in the system. Red cell contamination of marrow was also kept extremely low so preventing possible physical blockade of bead:tumour cell interaction. Marrow engraftment was rapid in this group, apart from patients who had been exposed to high doses of alkylating agents prior to autografting.
Similar articles
-
Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres.Lancet. 1984 Jan 14;1(8368):70-3. doi: 10.1016/s0140-6736(84)90004-7. Lancet. 1984. PMID: 6140424
-
Influence of single and double immunomagnetic depletion on the hemopoietic capacity of marrow in patients with advanced neuroblastoma submitted to autologous bone marrow transplantation.Bone Marrow Transplant. 1987 Dec;2(4):413-9. Bone Marrow Transplant. 1987. PMID: 3332188
-
Monoclonal antibodies and magnetic microspheres for the depletion of leukaemic cells from bone marrow harvested for autologous transplantation.Bone Marrow Transplant. 1987 Aug;2(2):133-9. Bone Marrow Transplant. 1987. PMID: 3332162
-
Immunomagnetic manipulation of bone marrow and tumour cells: an update.Prog Clin Biol Res. 1990;333:235-50; discussion 251. Prog Clin Biol Res. 1990. PMID: 2408061 Review.
-
Immunomagnetic purging of bone marrow: a model for negative cell selection.Am J Pediatr Hematol Oncol. 1990 Fall;12(3):257-61. doi: 10.1097/00043426-199023000-00002. Am J Pediatr Hematol Oncol. 1990. PMID: 2240471 Review.
Cited by
-
A comprehensive review on the applications of ferrite nanoparticles in the diagnosis and treatment of breast cancer.Med Oncol. 2024 Jan 10;41(2):53. doi: 10.1007/s12032-023-02277-2. Med Oncol. 2024. PMID: 38198041 Review.
-
Cytokeratin profile of immunomagnetically separated epithelial subsets of the human mammary gland.In Vitro Cell Dev Biol Anim. 1993 May;29A(5):427-32. doi: 10.1007/BF02633993. In Vitro Cell Dev Biol Anim. 1993. PMID: 7686143
-
Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.Indian J Pediatr. 1990 Jan-Feb;57(1):29-46. doi: 10.1007/BF02722127. Indian J Pediatr. 1990. PMID: 2193879 Review.
-
Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival.Pediatr Surg Int. 2008 Jan;24(1):101-5. doi: 10.1007/s00383-007-2033-4. Pediatr Surg Int. 2008. PMID: 17952444
-
Neuroblastoma: current drug therapy recommendations as part of the total treatment approach.Drugs. 2000 Jun;59(6):1261-77. doi: 10.2165/00003495-200059060-00006. Drugs. 2000. PMID: 10882162 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical